Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Poseida examines CAR-T conditioning to crack into solid tumors
Why haven’t CAR-T therapies cracked into solid tumors yet? Poseida Therapeutics is trying to fill in at least one piece of the puzzle at AACR.
Annalee Armstrong
Apr 10, 2024 10:32am
CAR-T for brain cancer extends survival in phase 1 trial
Mar 12, 2024 9:00am
Galapagos halts lupus CAR-T work, confirms 100 layoffs this year
Feb 23, 2024 8:28am
Q&A: Symphony founder's immunotherapy sponges set for space test
Feb 16, 2024 7:00am
Using cancer's 'superpower' to boost T-cell therapies in mice
Feb 12, 2024 3:30pm
BioNTech pays Autolus $250M to use manufacturing, CAR-T tech
Feb 8, 2024 9:17am